We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
PPL Gears Up for Q1 Earnings: What's in Store for the Stock?
Read MoreHide Full Article
PPL Corporation (PPL - Free Report) is set to release first-quarter 2021 results on May 6, before market open. The company delivered a negative earnings surprise of 4.23% in the trailing four quarters, on average.
Let’s discuss the factors that are likely to get reflected in the upcoming quarterly results.
Factors to Consider
With the reopening of the economy, demand from PPL Corp.’s commercial and industrial group might have improved in the to-be-reported quarter. Also, the same from the residential customers is likely to have further increased. Colder weather condition in some of the company’s service territories during this winter season is likely to supporting its results by bumping up demand.
Moreover, the utility’s efforts to manage costs effectively might have aided its performance to some extent.
Estimate
The Zacks Consensus Estimate for first-quarter earnings is pegged at 72 cents, indicating an increase of 7.46% from the year-ago quarter’s reported figure.
Earnings Whispers
Our proven model doesn’t predict an earnings beat for PPL Corp. this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. But that’s not the case here. You can see the complete list of today’s Zacks #1 Rank stocks here.
Earnings ESP: PPL Corp. has an Earnings ESP of -1.39%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Currently, PPL Corp. carries a Zacks Rank #3.
Stocks to Consider
Investors can consider the following players from the same industry that have the right combination of elements to beat on earnings this reporting cycle.
Consolidated Edison Inc (ED - Free Report) is set to release first-quarter 2021 results on May 6. It has an Earnings ESP of +0.06% and a Zacks Rank of 3, presently.
CenterPoint Energy, Inc. (CNP - Free Report) is set to release first-quarter 2021 results on May 6. It has an Earnings ESP of +4.52% and a Zacks Rank of 3, presently.
Duke Energy Corporation (DUK - Free Report) is set to release first-quarter 2021 results on May 10. It has an Earnings ESP of +0.16% and is currently a #3 Ranked player.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
PPL Gears Up for Q1 Earnings: What's in Store for the Stock?
PPL Corporation (PPL - Free Report) is set to release first-quarter 2021 results on May 6, before market open. The company delivered a negative earnings surprise of 4.23% in the trailing four quarters, on average.
Let’s discuss the factors that are likely to get reflected in the upcoming quarterly results.
Factors to Consider
With the reopening of the economy, demand from PPL Corp.’s commercial and industrial group might have improved in the to-be-reported quarter. Also, the same from the residential customers is likely to have further increased. Colder weather condition in some of the company’s service territories during this winter season is likely to supporting its results by bumping up demand.
Moreover, the utility’s efforts to manage costs effectively might have aided its performance to some extent.
Estimate
The Zacks Consensus Estimate for first-quarter earnings is pegged at 72 cents, indicating an increase of 7.46% from the year-ago quarter’s reported figure.
Earnings Whispers
Our proven model doesn’t predict an earnings beat for PPL Corp. this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. But that’s not the case here. You can see the complete list of today’s Zacks #1 Rank stocks here.
PPL Corporation Price and EPS Surprise
PPL Corporation price-eps-surprise | PPL Corporation Quote
Earnings ESP: PPL Corp. has an Earnings ESP of -1.39%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Currently, PPL Corp. carries a Zacks Rank #3.
Stocks to Consider
Investors can consider the following players from the same industry that have the right combination of elements to beat on earnings this reporting cycle.
Consolidated Edison Inc (ED - Free Report) is set to release first-quarter 2021 results on May 6. It has an Earnings ESP of +0.06% and a Zacks Rank of 3, presently.
CenterPoint Energy, Inc. (CNP - Free Report) is set to release first-quarter 2021 results on May 6. It has an Earnings ESP of +4.52% and a Zacks Rank of 3, presently.
Duke Energy Corporation (DUK - Free Report) is set to release first-quarter 2021 results on May 10. It has an Earnings ESP of +0.16% and is currently a #3 Ranked player.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>